Palmitate Induces Mitochondrial Energy Metabolism Disorder and Cellular Damage via the PPAR Signaling Pathway in Diabetic Cardiomyopathy
Xianyu Zhang,Min Mao,Zhong Zuo
DOI: https://doi.org/10.2147/DMSO.S360931
2022-08-02
Abstract:Xianyu Zhang, Min Mao, Zhong Zuo Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China Correspondence: Zhong Zuo, Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, No. 1, Medical College Road, Yuzhong District, Chongqing, 400016, People's Republic of China, Email Purpose: To establish an in vitro lipotoxicity model with mouse cardiomyocytes (MCMs) and investigate the molecular mechanism of the peroxisome proliferator-activated receptors (PPAR) signaling on mitochondrial energy metabolism disorder and cellular injury in diabetic cardiomyopathy (DCM). Methods: Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed on the differentially expressed genes (DEGs) of DCM. CCK-8 method was used to detect the proliferation inhibition effect of palmitate (PA) on MCMs. Oil red O staining and mRNA levels of CD36 were used to verify intracellular lipid accumulation. DCFH-DA method was used to determine the content of intracellular reactive oxygen species (ROS), and ATP levels were detected by the ATP Detection Kit. Transmission electron microscope (TEM) was used to observe the mitochondrial structure. Western blot was used to detect the expression levels of PPARα, PPARγ, P-mTOR, mTOR, PGC-1α, UCP2, and BNP. In addition, the expression of PPARγ was also detected by cellular immunofluorescence staining. BNP levels were detected by qRT-PCR and the ELISA Kit. Results: KEGG pathway analysis combined with GO analysis has shown that PPAR signaling played a significant regulatory role in mitochondrial biogenesis and fatty acid metabolism in DCM. Then, MCMs stimulated with PA for 24 h were selected as an in vitro lipotoxicity model. PA decreased cell viability, cell membrane shrinkage, and lipid accumulation. Meanwhile, PA-induced increase in cellular ROS led to ATP generation reduction and mitochondrial damage. Furthermore, the expression levels of p-mTOR- PPARα/γ were decreased, and the expressions of PGC-1α and UCP2 were increased. The levels of BNP were elevated, demonstrating PA impaired cardiomyocytes. Conclusion: Mitochondrial energy metabolism obstacle and cell injury appeared in cardiac lipotoxicity of DCM, associated with lipid accumulation and increased ROS, indicating a crosstalk with the PPAR pathway mediated mechanism. Keywords: diabetic cardiomyopathy, lipotoxicity, mitochondrial energy metabolism, cell damage, PPAR The global prevalence of diabetes is expected to be 12.2% in 2045, as reported by International Diabetes Federation (IDF). 1 Diabetes can aggravate the clinical symptoms and mortality of patients with heart failure. Cardiovascular complications are the leading causes of death in individuals with diabetes, among which diabetic cardiomyopathy (DCM) is one of the serious cardiovascular complications. 2 DCM refers to myocardial structure and function abnormalities in diabetic patients without coronary heart disease, hypertension, and other cardiovascular diseases. Its pathophysiological mechanisms include calcium homeostasis disorder, cardiac lipotoxicity, mitochondrial dysfunction, oxidative stress, and microvascular dysfunction. 3,4 Hyperglycemia, hyperlipidemia, and insulin resistance are independent risk factors for the DCM progression, inducing pathological hypertrophy, fibrosis, and metabolic disturbances in the heart. 5 If DCM is controlled improperly, it will eventually develop into heart failure. However, our knowledge of the key molecular mechanisms involved in DCM remains limited. Insulin resistance and hyperglycemia are frequently observed in diabetic patients, contributing to DCM development through several related mechanisms, including the release of predominant saturated free fatty acids (FFAs) from the adipose tissue and the breakdown of triglycerides. Circulating FFAs are taken up by many nonadipose tissues, including the heart, causing a reduction in the heart's ability to use glucose. As a result, the heart primarily has to rely on fatty acid oxidation (FAO) for energy, accompanied by higher rates of oxygen consumption and lower efficiency of energy metabolism, 6,7 leading to overproduction of reactive oxygen species (ROS), mitochondrial damage, and FFAs accumulation in the form of triglycerides in the heart tissue to promote myocardial steatosis. 8 Inappropriate accumulation of excess lipids will cause cardiomyocyte dysfunction and cell death in DCM, particularly in diabetic individuals. 9 Studies show that excessive saturated fatty acids uptake by cardiomyocytes causes myocardial mitochondria overload in diabetic patients, resulting in adverse myocardial function changes.<sup -Abstract Truncated-